Unknown

Dataset Information

0

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer.


ABSTRACT:

Aim

To evaluate whether PCR-reverse sequence-specific oligonucleotide can examine the concordance between liquid biopsy and metastatic lesions with acquired resistance.

Materials & methods

We examined acquired mutations in chemoresistant lesions and blood obtained from four patients with RAS wild-type metastatic colorectal cancer who underwent treatment with anti-epidermal growth factor receptor antibodies.

Results

In one patient, metastatic lesions harbored diverse acquired mutations in KRAS in all seven metastases; the two acquired mutations were detectable in blood collected after the patient acquired resistance. None of the other patients exhibited liquid biopsy mutations, except one, with a BRAF mutation confirmed in primary tumor and peritoneal dissemination.

Conclusion

Liquid biopsy based on PCR-reverse sequence-specific oligonucleotide is a successful procedure for capturing acquired mutations with precise information on the RAS mutational spectrum.

SUBMITTER: Taniguchi F 

PROVIDER: S-EPMC8609982 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4189196 | biostudies-literature
| S-EPMC8197329 | biostudies-literature
| S-EPMC9068964 | biostudies-literature
| S-EPMC6288144 | biostudies-literature
| PRJEB9202 | ENA
| S-EPMC7205246 | biostudies-literature
| S-EPMC6483502 | biostudies-literature
| S-EPMC6827157 | biostudies-literature
| S-EPMC5559326 | biostudies-literature
| S-EPMC7055306 | biostudies-literature